Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.

Literature DB >> 12433319

A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.

P Sandercock¹, E Berge, M Dennis, J Forbes, P Hand, J Kwan, S Lewis, R Lindley, A Neilson, B Thomas, J Wardlaw.

Abstract

Entities: Disease

Mesh：

Substances：
Neuroprotective Agents

Year: 2002 PMID： 12433319 DOI： 10.3310/hta6260

Source DB: PubMed Journal: Health Technol Assess ISSN： 1366-5278 Impact factor: 4.014

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. Clarification of terminology in drug safety.

Authors: Jeffrey K Aronson; Robin E Ferner
Journal: Drug Saf Date: 2005 Impact factor: 5.606

Review 2. Thrombolysis in acute ischaemic stroke: a guide to patient selection.

Authors: Richard I Lindley
Journal: CNS Drugs Date: 2005 Impact factor: 5.749

3. Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis.

Authors: Claire de Oliveira; Hai V Nguyen; Harindra C Wijeysundera; William W L Wong; Gloria Woo; Paul Grootendorst; Peter P Liu; Murray D Krahn
Journal: CMAJ Open Date: 2013-07-25

Review 4. Modeling stroke management: a qualitative review of cost-effectiveness analyses.

Authors: Chantal Guilhaume; Delphine Saragoussi; John Cochran; Clément François; Mondher Toumi
Journal: Eur J Health Econ Date: 2010-03-18

Review 5. Alteplase for the treatment of acute ischaemic stroke: a NICE single technology appraisal; an evidence review group perspective.

Authors: Michael Holmes; Sarah Davis; Emma Simpson
Journal: Pharmacoeconomics Date: 2015-03 Impact factor: 4.981

6. A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia.

Authors: Zhi-Gang Jiang; X-C May Lu; Valery Nelson; Xiaofang Yang; Weiying Pan; Ren-wu Chen; Michael S Lebowitz; Bijan Almassian; Frank C Tortella; Roscoe O Brady; Hossein A Ghanbari
Journal: Proc Natl Acad Sci U S A Date: 2006-01-19 Impact factor: 11.205

7. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.

Authors: Lars Ehlers; Wilhelmina Maria Müskens; Lotte Groth Jensen; Mette Kjølby; Grethe Andersen
Journal: CNS Drugs Date: 2008 Impact factor: 5.749